Kolexia
Buchmuller Andréa Médecine générale
Buchmuller Andréa
Médecine générale
Hôpital Nord CHU Saint-Étienne - Loire
Saint-Priest-en-Jarez, France
39 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thromboembolisme veineux Thromboembolie Thrombose Thrombose veineuse Hémorragie Embolie pulmonaire Embolie Thrombophlébite Hémorragie de la délivrance

Collaborateurs

Voir plus
Bertoletti Laurent
Bertoletti Laurent
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Chauleur Céline
Chauleur Céline
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Mismetti Patrick
Mismetti Patrick
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Tardy Bernard
Tardy Bernard
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France

Industries

Voir plus
Amgen
1 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study.
Journal of thrombosis and haemostasis : JTH   22 décembre 2022
Inferior vena cava filters in pregnancy: Safe or sorry?
Frontiers in cardiovascular medicine   07 novembre 2022
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.
Lancet (London, England)   28 octobre 2022
Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism.
Blood   24 octobre 2022
Risk and impact of anticoagulation-associated abnormal menstrual bleeding in women of reproductive age with venous thromboembolism – The TEAM-VTE study
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Intermediate versus low-dose low-molecular-weight heparin in pregnant and postpartum women with a history of venous thromboembolism (Highlow Study)
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Highlow: Low-molecular-weight Heparin to Prevent Recurrent VTE in Pregnancy: a Randomized Controlled Trial of Two Doses
Essai Clinique (Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA))   21 mai 2022
TEAM-VTE: Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding in Female Patients With VTE
Essai Clinique (Leiden University Medical Center)   06 février 2021
Thromboprophylaxis in pregnant women: For whom and which LMWH dosage?
Journal of thrombosis and haemostasis : JTH   23 avril 2020
Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC.
Journal of thrombosis and haemostasis : JTH   12 août 2019